The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: A prospective, longitudinal, randomized, double-blind trial with calcitriol

Transplantation

Volumn 73, Issue 4, 2002, Pages 547-552

  Stempfle, Hans Ulrich ^a   Werner, Christiane ^a   Siebert, Uwe ^a   Assum, Tanja ^a   Wehr, Uli ^a   Rambeck, Walter A ^a   Meiser, Bruno ^a   Theisen, Karl ^a   Gartner, Roland ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; PLACEBO; TACROLIMUS; TESTOSTERONE ENANTATE;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FEMUR NECK; FRACTURE; HEART TRANSPLANTATION; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; IMMUNOSUPPRESSIVE TREATMENT; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; OSTEOLYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0037181121     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200202270-00010     Document Type: Article

References (26)

1. FK506 effectiveness in reducing acute rejection after heart transplantation: A prospective randomized study
2. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: Decreased hyperlipidemia and hypertension with tacrolimus
3. The deleterious effects of long-term cyclosporin A, cyclosporin G, and FK506 on bone mineral metabolism in vivo
4. Rapid trabecular bone loss after cardiac transplantation using FK506 (Tacrolimus) based immunosuppression
5. Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis
6. Glucocorticoid induced osteoporosis: Pathogenesis and management
7. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group
8. Perspective. The diagnosis of osteoporosis
9. Classification of vertebral fractures
10. Bone loss after heart transplantation: A prospective study
11. Bone loss after cardiac transplantation: Effects of calcium, calcidiol and monofluorophosphate
12. Prevention of osteoporosis after cardiac transplantation
13. Bone loss and turnover after cardiac transplantation
14. Azathioprine alone is bone sparing and does not alter Cyclosporin-A-induced osteopenia in the rat
15. Mycophenolate mofetil: A promising new immunosuppressant that does not cause bone loss in the rat
16. Effect of glucocorticoids on function of the parathyroid glands in man
17. Effects of short term glucocorticoid administration on in-testinal calcium absorption and circulating vitamin D metabolite concentrations in man
18. Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration
19. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone
20. Increased sensitivity of bone to parathyroid hormone in ovariectomized rats
21. Calcium metabolism in early chronic renal failure: Implications for the pathogenesis of hyperparathyroidism
22. Low-dose calcitriol prevents the rise in 1,84iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial)
23. Mechanisms of bone loss after cardiac transplantation
24. The role of testosterone in cyclosporine-induced osteopenia
25. Effect of FK506 on rat leydig cell function - In vivo and in vitro study